Physician profile
Rajat Kumar
NPI 1982962734
$7,439.73
in general payments reported to CMS, 2019-2025
8 companies · $2,224 in 2025
The $2,224 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,062 · 2020: $14.37 · 2021: $218 · 2023: $152 · 2024: $1,770 · 2025: $2,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,928 · Consulting Fee: $1,645 · Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,928.08 |
| Consulting Fee | $1,645.00 |
| Food and Beverage | $573.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,308.72 | 2019-2025 | Advantagerib, Ribfix Titan |
| Intuitive Surgical, INC. | $1,615.69 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,575.00 | 2024 | Imfinzi |
| Veran Medical Technologies, INC. | $1,353.11 | 2019 | |
| Atricure, INC. | $463.75 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $70.00 | 2023-2025 | Surgipro Ll, Eea |
| Janssen Pharmaceuticals, INC | $39.09 | 2024 | Xarelto |
| Baxter Healthcare | $14.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajat Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.